Cargando…
The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts
OBJECTIVE: Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART). Financial constraints do not allow most developing countries to adopt a universal test and offer ART strategy. Decentralizing CD4+ T cell testing may, therefore, provide greater access t...
Autores principales: | Bwana, Priska, Vojnov, Lara, Adhiambo, Maureen, Akinyi, Catherine, Mwende, Joy, Prescott, Marta, Mwau, Matilu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697849/ https://www.ncbi.nlm.nih.gov/pubmed/26720601 http://dx.doi.org/10.1371/journal.pone.0145586 |
Ejemplares similares
-
Correction: The BD FACSPresto Point of Care CD4 Test accurately enumerates CD4+ T cell counts
por: Bwana, Priska, et al.
Publicado: (2016) -
Technical Performance Evaluation of the MyT4 Point of Care Technology for CD4+ T Cell Enumeration
por: Mwau, Matilu, et al.
Publicado: (2014) -
The performance of BD FACSPresto™ for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia
por: Gebremicael, Gebremedhin, et al.
Publicado: (2017) -
Performance evaluation of BD FACSPresto(™) point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria
por: Negedu-Momoh, Olubunmi Ruth, et al.
Publicado: (2017) -
Scale-up of Kenya’s national HIV viral load program: Findings and lessons learned
por: Mwau, Matilu, et al.
Publicado: (2018)